Yong Ben
Board Member
Corbus Pharmaceuticals Holdings, Inc. (CRBP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Yong Ben
Yong Ben is recorded as Board Member at Corbus Pharmaceuticals Holdings, Inc. (CRBP). Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 20, 2024 that Yong Ben was appointed director, effective May 16, 2024. Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed March 7, 2023 that Yong Ben was appointed Board of Directors, effective March 1, 2023.
“The election of each of Yuval Cohen, Alan Holmer, Avery W. Catlin, Rachelle Jacques, John Jenkins, Peter Salzmann, Anne Altmeyer and Yong Ben as directors to hold office for a term of one year, until his or her successor is duly elected and qualified or he or she is otherwise unable to complete his or her term.”
“Dr. Yong Ben joined the Corbus Board of Directors on March 1, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Corbus Pharmaceuticals Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Yuval Cohen CEO, Board Member
- Alan Holmer Chairman, Board Member
- Sean Moran CFO
- Ian Hodgson COO
- Anne Altmeyer Board Member
- Anne Altmeyer, Ph.D., MBA, MPH Board Member
- Avery W. Catlin Board Member
- Brent Pfeiffenberger Board Member
- George S. Golumbeski Board Member
- John Jenkins Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.